Our results demonstrated that the number of Tc17 (defined as CD3+CD8+IL-17+) was significantly increased in newly-diagnosed patients, but not in patients who had CR, which indicated the importance of Tc17 in the development of ITP. The gene discussed is CD8A; the disease is autoimmune thrombocytopenic purpura.